Special considerations and pitfalls for intracerebral bleeding followed COVID-19 case treated by ECMO

COVID-19, or coronavirus infection, is an acute respiratory illness caused by the corona virus that can develop into a life-threatening form of ARDS. Extracorporeal membrane oxygenation (ECMO) is a highly effective treatment for life-threatening instances. One of the many complications associated wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Amer, Wael Osman, El Gharieb, Hussein Awad, Ahmed, Zakaria, Ibrahim, Hossam, Alanazi, Ahmed, Meshref, Mostafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020 International Hemorrhagic Stroke Association. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257510/
https://www.ncbi.nlm.nih.gov/pubmed/37359506
http://dx.doi.org/10.1016/j.hest.2023.06.001
Descripción
Sumario:COVID-19, or coronavirus infection, is an acute respiratory illness caused by the corona virus that can develop into a life-threatening form of ARDS. Extracorporeal membrane oxygenation (ECMO) is a highly effective treatment for life-threatening instances. One of the many complications associated with ECMO was bleeding. COVID patients are at risk for intracerebral bleeding due to several factors, including the drug's action on ACE2 receptors, leading to hypertension, as well as hypercoagulability, dysregulated immune response, DIC, and the use of anticoagulants.

Ejemplares similares